69 related articles for article (PubMed ID: 18220499)
1. Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation.
Imai K
Clin Interv Aging; 2013; 8():681-8. PubMed ID: 23766643
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Oral Alendronate Treatment in Children and Adolescents with Osteoporosis.
Unal E; Abaci A; Bober E; Büyükgebiz A
J Pediatr Endocrinol Metab; 2006 Apr; 19(4):523-528. PubMed ID: 38742779
[No Abstract] [Full Text] [Related]
3. Ångstrom-scale gold particles loaded with alendronate via alpha-lipoic acid alleviate bone loss in osteoporotic mice.
Gao W; Li JJ; Shi J; Lan H; Guo Y; Fu D
J Nanobiotechnology; 2024 Apr; 22(1):212. PubMed ID: 38689294
[TBL] [Abstract][Full Text] [Related]
4. A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study.
Lee WY; Sun LM; Lin MC; Liang JA; Chang SN; Sung FC; Muo CH; Kao CH
PLoS One; 2012; 7(12):e53032. PubMed ID: 23300854
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties.
Ma S; Goh EL; Jin A; Bhattacharya R; Boughton OR; Patel B; Karunaratne A; Vo NT; Atwood R; Cobb JP; Hansen U; Abel RL
Sci Rep; 2017 Mar; 7():43399. PubMed ID: 28262693
[TBL] [Abstract][Full Text] [Related]
6. Fosamax Fractures-Justice Has Not Been Served.
Curfman G
JAMA; 2024 Jun; 331(22):1887-1888. PubMed ID: 38748439
[TBL] [Abstract][Full Text] [Related]
7. The analysis of alendronate action in bone fracture healing in rats.
Baima Filho FAS; Mendonça PG; Silva GEB; Santos OJD; Garcia JBS; Cartagenes MDSS
J Clin Orthop Trauma; 2020 Oct; 11(Suppl 5):S856-S860. PubMed ID: 32999568
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a gastroretentive dosage form composed of chitosan and hydroxyethyl cellulose for alendronate.
Chen YC; Ho HO; Chiu CC; Sheu MT
Drug Des Devel Ther; 2014; 8():67-78. PubMed ID: 24403821
[TBL] [Abstract][Full Text] [Related]
9. Alendronate Release from UHMWPE-Based Biomaterials in Relation to Particle Size of the GUR Powder for Manufacturing.
Seidenstuecker M; Weber J; Latorre SH; Straub B; Matthes U; Friedrich C; Mayr HO; Bernstein A
Materials (Basel); 2019 Jun; 12(11):. PubMed ID: 31174252
[TBL] [Abstract][Full Text] [Related]
10. Design and Biological Evaluation of Delivery Systems Containing Bisphosphonates.
Aderibigbe B; Aderibigbe I; Popoola P
Pharmaceutics; 2016 Dec; 9(1):. PubMed ID: 28035945
[TBL] [Abstract][Full Text] [Related]
11. Analysis of daily teriparatide treatment for osteoporosis in men.
Niimi R; Kono T; Nishihara A; Hasegawa M; Matsumine A; Kono T; Sudo A
Osteoporos Int; 2015 Apr; 26(4):1303-9. PubMed ID: 25567777
[TBL] [Abstract][Full Text] [Related]
12. Bone-crack detection, targeting, and repair using ion gradients.
Yadav V; Freedman JD; Grinstaff M; Sen A
Angew Chem Int Ed Engl; 2013 Oct; 52(42):10997-1001. PubMed ID: 24039057
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies.
Mak A; Cheung MW; Ho RC; Cheak AA; Lau CS
BMC Musculoskelet Disord; 2009 Sep; 10():113. PubMed ID: 19772579
[TBL] [Abstract][Full Text] [Related]
14. Alendronate for the treatment of osteoporosis in men.
Olszynski WP; Davison KS
Expert Opin Pharmacother; 2008 Feb; 9(3):491-8. PubMed ID: 18220499
[TBL] [Abstract][Full Text] [Related]
15. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Saag KG; Shane E; Boonen S; Marín F; Donley DW; Taylor KA; Dalsky GP; Marcus R
N Engl J Med; 2007 Nov; 357(20):2028-39. PubMed ID: 18003959
[TBL] [Abstract][Full Text] [Related]
16. Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02.
Orimo H; Nakamura T; Fukunaga M; Ohta H; Hosoi T; Uemura Y; Kuroda T; Miyakawa N; Ohashi Y; Shiraki M;
Curr Med Res Opin; 2011 Jun; 27(6):1273-84. PubMed ID: 21554143
[TBL] [Abstract][Full Text] [Related]
17. Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial.
Tamechika SY; Sasaki K; Hayami Y; Ohmura SI; Maeda S; Iwagaitsu S; Naniwa T
Arch Osteoporos; 2018 Jun; 13(1):67. PubMed ID: 29904824
[TBL] [Abstract][Full Text] [Related]
18. Long-term experience with alendronate in the treatment of osteoporosis.
Hochberg MC; Rizzoli R
Expert Opin Pharmacother; 2006 Jun; 7(9):1201-10. PubMed ID: 16732706
[TBL] [Abstract][Full Text] [Related]
19. Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women.
Sawka AM; Papaioannou A; Adachi JD; Gafni A; Hanley DA; Thabane L
BMC Musculoskelet Disord; 2005 Jul; 6():39. PubMed ID: 16008835
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
